bezafibrate has been researched along with phenyl acetate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergseth, S; Bremer, J; Christiansen, EN; Leighton, F; Rørtveit, T | 1 |
| Ikeda, S; Kusama, H; Matsubara, Y; Nishiyama, M | 1 |
| Hirose, M; Isobe, E; Kanegae, T; Nagoya, T; Shimamura, M; Tsukamoto, S | 1 |
| Bottoni, P; Castagnola, M; De Sole, P; Giardina, B; Maggiano, N; Martorana, GE; Messana, I; Nocca, G; Scatena, R; Vincenzoni, F | 1 |
| Buckley, KA; Chan, BY; Dillon, JP; Fraser, WD; Gallagher, JA; Gartland, A; Wilson, PJ | 1 |
| Hirschfield, GM; Webb, GJ | 1 |
1 review(s) available for bezafibrate and phenyl acetate
| Article | Year |
|---|---|
Work in Progress: Drugs in Development.
Topics: Abatacept; Acetates; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Bezafibrate; CD40 Antigens; CD40 Ligand; Chalcones; Chemokine CX3CL1; Chenodeoxycholic Acid; Cholic Acids; Drug Development; Fenofibrate; Fibroblast Growth Factors; Humans; Hypolipidemic Agents; Immunosuppressive Agents; Janus Kinase Inhibitors; Liver Cirrhosis, Biliary; Methylamines; Peroxisome Proliferator-Activated Receptors; PPAR alpha; PPAR delta; PPAR gamma; Propionates; Pruritus; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Thiazepines; Triazoles; Ustekinumab | 2018 |
5 other study(ies) available for bezafibrate and phenyl acetate
| Article | Year |
|---|---|
Free acetate production by rat hepatocytes during peroxisomal fatty acid and dicarboxylic acid oxidation.
Topics: Acetates; Animals; Bezafibrate; Cells, Cultured; Dicarboxylic Acids; Fatty Acids; Hydrogen Peroxide; Ketone Bodies; Kinetics; Liver; Male; Microbodies; Oxidation-Reduction; Rats; Rats, Inbred Strains | 1989 |
[Pharmacological investigation of bezafibrate, a hypolipidemic agent (2). Mechanism of the hypolipidemic action of bezafibrate in rats].
Topics: Acetates; Acetyl-CoA Carboxylase; Animals; Anticholesteremic Agents; Bezafibrate; Cholesterol; Hydroxymethylglutaryl CoA Reductases; Lipoprotein Lipase; Liver; Male; Oxidation-Reduction; Rats; Rats, Inbred Strains; Triglycerides | 1988 |
Effects of bezafibrate on ethanol oxidation in rats.
Topics: Acetates; Alcoholic Intoxication; Aldehydes; Animals; Bezafibrate; Ethanol; Fatty Acids; Linoleic Acid; Linoleic Acids; Liver; Male; Microbodies; Oxidation-Reduction; Rats; Rats, Wistar | 1996 |
Bezafibrate induces a mitochondrial derangement in human cell lines: a PPAR-independent mechanism for a peroxisome proliferator.
Topics: Acetates; Alanine; Animals; Bezafibrate; Dose-Response Relationship, Drug; Humans; Hypolipidemic Agents; Italy; Lactic Acid; Magnetic Resonance Spectroscopy; Microscopy, Electron; Mitochondria; Mitochondrial Diseases; Peroxisome Proliferators; Rats; Time Factors; Tumor Cells, Cultured | 2003 |
PPAR agonists modulate human osteoclast formation and activity in vitro.
Topics: Acetates; Apoptosis; Bezafibrate; Bone Resorption; Butyrates; Cells, Cultured; Fenofibrate; Humans; Hypolipidemic Agents; Leukocytes, Mononuclear; Macrophage Colony-Stimulating Factor; Osteoclasts; Peroxisome Proliferator-Activated Receptors; Phenols; Phenoxyacetates; Phenylurea Compounds; RANK Ligand; RNA, Messenger; Thiazolidinediones; Transcription, Genetic | 2007 |